Logo

NEWSBRIEF: Orchid, Merck Partner to Study Pharmacogenomics

May 01, 2002

NEW YORK, May 1 - Orchid BioSciences said today that its GeneShield business has inked a pharmacogenomic partnership with Merck unit Merck-Medco.

 

The deal calls for the partners to conduct a retrospective clinical pharmacogenomic study of asthma patients undergoing care in a managed care setting.

 

Click here for more information.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.